Bristol-Myers Squibb
BMY
#201
Rank
โ‚ฌ88.67 B
Marketcap
43,56ย โ‚ฌ
Share price
-1.97%
Change (1 day)
-18.83%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): 2,62ย โ‚ฌ

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is 2,55ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,80ย โ‚ฌ a decrease over its 2023 EPS that were of 3,34ย โ‚ฌ.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)2,62ย โ‚ฌ-168.93%
2024-3,80ย โ‚ฌ-213.92%
20233,34ย โ‚ฌ30.2%
20222,56ย โ‚ฌ-6.04%
20212,73ย โ‚ฌ-179.29%
2020-3,44ย โ‚ฌ-281.37%
20191,90ย โ‚ฌ-27.21%
20182,61ย โ‚ฌ
20162,30ย โ‚ฌ175.26%
20150,83ย โ‚ฌ-19.83%
20141,04ย โ‚ฌ-22.44%
20131,34ย โ‚ฌ34.48%
20121,00ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,48ย โ‚ฌ-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,53ย โ‚ฌ 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
17,65ย โ‚ฌ 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,33ย โ‚ฌ 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
3,19ย โ‚ฌ 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
2,61ย โ‚ฌ 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
8,98ย โ‚ฌ 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,16ย โ‚ฌ-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
11,21ย โ‚ฌ 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
9,45ย โ‚ฌ 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA